1

2

3

4
Dai Yujia, Davidsen Steven K, Ericsson Anna M, Hartandi Kresna, Ji Zhiqin, Michaelides Michael R: Indazole, benzisoxazole, and benzisothiazole kinase inhibitors. Abbott Laboratories, Dai Yujia, Davidsen Steven K, Ericsson Anna M, Hartandi Kresna, Ji Zhiqin, Michaelides Michael R, STEELE Gregory, December 29, 2004: WO/2004/113304 (37 worldwide citation)

Compounds having the formula (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.


5
George Dawn M, Wang Lu, Li Biqin, Ericsson Anna M, Ansell Graham K: Octahydropentalene compounds as chemokine receptor antagonists. Abbott Laboratories, George Dawn M, Wang Lu, Li Biqin, Ericsson Anna M, Ansell Graham K, O BRIEN Gayle B, April 2, 2009: WO/2009/042193 (22 worldwide citation)

The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts thereof, pro-drugs thereof, biologically active metabolites thereof, isomers thereof or stereoisomers thereof wherein the variables are as defined herein. The compounds of Formula (I) are useful as ...


6

7

8

9
Dai Yujia, Davidsen Steven K, Ericsson Anna M, Hartandi Kresna, Ji Zhiqin, Michaelides Michael R: Indazole, benzisoxazole, and benzisothiazole kinase inhibitors. Abbott Lab, November 3, 2010: EP2246333-A1

Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.


10